Health Care Reform and Investment in New Drug Development.

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service.

Language:

English

Subjects (All):

Health facilities.

Medicine--Research.

Medicine.

Pharmaceutical industry.

Physical Description:

1 online resource (33 pages) : digital, PDF file

monochrome

Place of Publication:

[Place of publication not identified] : [publisher not identified], 1995-1996.

System Details:

System requirements: PDF reader software.

text file

PDF

Summary:

Examines the implications of health care reform for pharmaceutical innovation. Describes the dominant features of the drug development process and the forces shaping the current U.S. prescription drug market. Discusses the elements of recent proposals for health care reform that are likely to have the biggest impact on the incentives to invest in the development of new drugs, and how those elements, individually and together, could affect those incentives.

Notes:

CRS Report.

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.

Other Format:

Microfiche version: Library of Congress. Congressional Research Service. Health Care Reform and Investment in New Drug Development

Access Restriction:

Restricted for use by site license.